Filing Flows › Corvel (CRVL) › Stock forecast & fair value
Corvel (CRVL) stock forecast and fair value
Corvel (CRVL) trades at $78.05. Across 12 valuation methods the middle fair value is $36.34 (-53%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| P/E vs peers | $45.10 | $55.81 | $99.67 | -28% |
| P/E vs peers, weighted | $44.84 | $56.04 | $77.51 | -28% |
| P/E vs peers, matched | $56.28 | $80.61 | $202.18 | +3% |
| Residual income | $14.73 | $15.31 | $15.92 | -80% |
| P/B vs ROE (insurer peers) | $11.52 | $23.08 | $34.64 | -70% |
| Shareholder yield (dividends + buybacks) | $17.15 | $20.21 | $24.61 | -74% |
| Justified P/B (Gordon growth) | $38.13 | $47.44 | $62.76 | -39% |
| Stage-weighted value (financial (bank / insurer)) | $22.24 | $29.54 | $41.87 | -62% |
| Combined forecast (3 months) | $63.63 | $80.88 | $100.27 | +4% |
| Graham number | $16.51 | $20.23 | $23.36 | -74% |
Corvel's latest quarter
Corvel, Q2 FY27: revenue $267M (+12% year over year), operating margin 17.2%, net earnings $34.1M, operating cash flow $39.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Corvel's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $15.31 and $80.88, with a middle value of $36.34 against a price of $78.05. Each method's assumptions are on the page.
Does Corvel usually beat earnings estimates?
It beat the consensus EPS estimate in 0% of the quarters on record.
Is CRVL stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.